Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Rabkin, Samuel
Item TypeName
Academic Article Oncolytic herpes simplex virus therapy for peripheral nerve tumors.
Academic Article Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.
Academic Article Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect.
Academic Article Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
Academic Article Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
Academic Article Hypoxia enhances the replication of oncolytic herpes simplex virus.
Academic Article Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.
Academic Article Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.
Academic Article Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures.
Academic Article Expression of FMS-like tyrosine kinase 3 ligand by oncolytic herpes simplex virus type I prolongs survival in mice bearing established syngeneic intracranial malignant glioma.
Academic Article Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication.
Academic Article Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma.
Academic Article Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.
Academic Article Combination immunotherapy for tumors via sequential intratumoral injections of oncolytic herpes simplex virus 1 and immature dendritic cells.
Academic Article Oncolytic herpes simplex virus treatment of metastatic breast cancer.
Academic Article Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors.
Academic Article Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects.
Academic Article Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.
Academic Article Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models.
Academic Article Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy.
Academic Article Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging.
Academic Article Effect of ?34.5 deletions on oncolytic herpes simplex virus activity in brain tumors.
Academic Article Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells.
Academic Article Treatment of breast cancer stem cells with oncolytic herpes simplex virus.
Academic Article Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.
Academic Article A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.
Academic Article Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair.
Academic Article Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts.
Academic Article Systemic oncolytic herpes virus therapy of poorly immunogenic prostate cancer metastatic to lung.
Academic Article Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
Academic Article Treatment of implantable NF2 schwannoma tumor models with oncolytic herpes simplex virus G47Delta.
Concept Oncolytic Virotherapy
Academic Article Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model.
Academic Article Immunovirotherapy for glioblastoma.
Academic Article Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus.
Academic Article Oncolytic viruses and their application to cancer immunotherapy.
Academic Article Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.
Academic Article Treatment of human thyroid carcinoma cells with the g47delta oncolytic herpes simplex virus.
Academic Article A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.
Academic Article Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
Academic Article Blockade of transforming growth factor-ß signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
Academic Article Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade.
Academic Article Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
Academic Article Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma.
Academic Article MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation.
Academic Article Immunohistochemistry for Tumor-Infiltrating Immune Cells After Oncolytic Virotherapy.
Academic Article Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma.
Academic Article The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy?
Academic Article Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.
Academic Article Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus.
Search Criteria
  • Oncolytic Virotherapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.